Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication

CompletedOBSERVATIONAL
Enrollment

1,730

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

July 31, 2025

Conditions
Helicobacter Pylori Infection
Interventions
OTHER

This study is a retrospective study, and all data have been collected in advance with no active intervention required.

This study is a retrospective study, and all data have been collected in advance with no active intervention required.

Trial Locations (1)

250012

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors
collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Zaozhuang Municipal Hospital

OTHER

collaborator

Shandong University of Traditional Chinese Medicine

OTHER

collaborator

Qihe County People's Hospital

UNKNOWN

collaborator

Taierzhuang District People's Hospital

OTHER

collaborator

University Town Hospital, Affiliated Hospital of Shandong University of Traditional Chinese Medicine

UNKNOWN

collaborator

Dezhou Hospital Qilu Hospital of Shandong University

OTHER

lead

Yueyue Li

OTHER

NCT07167511 - Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication | Biotech Hunter | Biotech Hunter